Bahl & Gaynor’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
+517
| New | +$201K | ﹤0.01% | 324 |
|
|
2024
Q3 | – | Sell |
-373
| Closed | -$202K | – | 344 |
|
|
2024
Q2 | $202K | Sell |
373
-26
| -7% | -$14.1K | ﹤0.01% | 328 |
|
|
2024
Q1 | $207K | Buy |
+399
| New | +$207K | ﹤0.01% | 329 |
|
|
2023
Q2 | – | Sell |
-450
| Closed | -$207K | – | 348 |
|
|
2023
Q1 | $207K | Buy |
450
+8
| +2% | +$3.68K | ﹤0.01% | 331 |
|
|
2022
Q4 | $227K | Buy |
+442
| New | +$227K | ﹤0.01% | 322 |
|
|
2022
Q1 | – | Sell |
-737
| Closed | -$342K | – | 339 |
|
|
2021
Q4 | $342K | Hold |
737
| – | – | ﹤0.01% | 302 |
|
|
2021
Q3 | $275K | Hold |
737
| – | – | ﹤0.01% | 317 |
|
|
2021
Q2 | $281K | Hold |
737
| – | – | ﹤0.01% | 320 |
|
|
2021
Q1 | $265K | Hold |
737
| – | – | ﹤0.01% | 322 |
|
|
2020
Q4 | $237K | Buy |
+737
| New | +$237K | ﹤0.01% | 321 |
|
|
2020
Q1 | – | Sell |
-704
| Closed | -$213K | – | 343 |
|
|
2019
Q4 | $213K | Buy |
+704
| New | +$213K | ﹤0.01% | 344 |
|
|
2019
Q2 | – | Sell |
-706
| Closed | -$203K | – | 355 |
|
|
2019
Q1 | $203K | Buy |
+706
| New | +$203K | ﹤0.01% | 341 |
|
|
2018
Q1 | – | Sell |
-1,306
| Closed | -$294K | – | 403 |
|
|
2017
Q4 | $294K | Hold |
1,306
| – | – | ﹤0.01% | 373 |
|
|
2017
Q3 | $248K | Hold |
1,306
| – | – | ﹤0.01% | 377 |
|
|
2017
Q2 | $246K | Hold |
1,306
| – | – | ﹤0.01% | 389 |
|
|
2017
Q1 | $216K | Sell |
1,306
-145
| -10% | -$24K | ﹤0.01% | 379 |
|
|
2016
Q4 | $209K | Buy |
+1,451
| New | +$209K | ﹤0.01% | 378 |
|
|
2016
Q2 | – | Sell |
-1,778
| Closed | -$247K | – | 405 |
|
|
2016
Q1 | $247K | Hold |
1,778
| – | – | ﹤0.01% | 379 |
|
|
2015
Q4 | $248K | Sell |
1,778
-28
| -2% | -$3.91K | ﹤0.01% | 389 |
|
|
2015
Q3 | $253K | Buy |
1,806
+28
| +2% | +$3.92K | ﹤0.01% | 391 |
|
|
2015
Q2 | $292K | Buy |
+1,778
| New | +$292K | ﹤0.01% | 395 |
|